Rossella Medori

Affiliations: 
Università di Bologna, Bologna, Italy 
Google:
"Rossella Medori"
Mean distance: 17.19 (cluster 28)
 
SNBCP
Cross-listing: Neuropathology Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hupperts R, Lycke J, Short C, et al. (2015) Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial. Multiple Sclerosis (Houndmills, Basingstoke, England)
Magistrale G, Pisani V, Argento O, et al. (2015) Validation of the World Health Organization Disability Assessment Schedule II (WHODAS-II) in patients with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 448-56
Phillips GA, Wyrwich KW, Guo S, et al. (2014) Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1753-60
Bushnell SE, Zhao Z, Stebbins CC, et al. (2012) Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS. Neurology. 79: 531-7
Buitelaar J, Medori R. (2010) Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants. European Child & Adolescent Psychiatry. 19: 325-40
Mauri MC, Turner M, Volonteri LS, et al. (2009) Dosing patterns in Europe: Efficacy and safety of risperidone long-acting injectable in doses of 25, 37.5 and 50 mg. International Journal of Psychiatry in Clinical Practice. 13: 36-47
Buitelaar JK, Ramos-Quiroga JA, Casas M, et al. (2009) Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Neuropsychiatric Disease and Treatment. 5: 457-66
Bräunig P, Sacchetti E, Medori R. (2008) Risperidone long-acting injectable for maintenance therapy in bipolar disorder: An open-label pilot study. International Journal of Psychiatry in Clinical Practice. 12: 74-7
Emsley R, Oosthuizen P, Koen L, et al. (2008) Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Clinical Therapeutics. 30: 2378-86
Emsley R, Oosthuizen P, Koen L, et al. (2008) Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection. International Clinical Psychopharmacology. 23: 325-31
See more...